The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features
Authors:
- 11 July 2023
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 7 (2) , 266-274
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Comprehensive Characterization of the Perioperative Morbidity of Cytoreductive NephrectomyEuropean Urology, 2016
- Multi-Quadrant Biopsy Technique Improves Diagnostic Ability in Large Heterogeneous Renal MassesJournal of Urology, 2015
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumEuropean Urology, 2014
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based studyThe Lancet Oncology, 2013
- Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?Cancer, 2010
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter StudyJournal of Clinical Oncology, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Decision Curve Analysis: A Novel Method for Evaluating Prediction ModelsMedical Decision Making, 2006
- Interferon-Alfa as a Comparative Treatment for Clinical Trials of New Therapies Against Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 2002
- Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trialThe Lancet, 2001